MAYNE PHARMA GROUP LIMITED — Director's Dealing 2012

Dec 2, 2012

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Mayne Pharma Group Limited
ABN	76 115 832 963

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the followingthe director for the purposes of section	information under listing rule 3.19A.2 and as agent for205G of the Corporations Act.
Name of Director	Ian Scholes
Date of last notice	7 November 2012

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and Indirect interest
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	1) UBS Wealth Management AustraliaNominees Pty Ltd2) Direct Interest
Date of change	30 November 2012
No. of securities held prior to change	623,244Ordinary Fully Paid Shares (1)250,000Unlisted options for ordinaryshares @ 60 cents expiring 30November 2012 (2)350,000Unlisted options for ordinaryshares @ 27 cents expiring 31December 2012 (2)
Class	Unlisted options for ordinary shares @60cents expiring 30 November 2012 (2)
Number acquired	Nil
Number disposed	250,000 options expired

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Nil Note: If consideration is non-­‐cash, provide details and estimated valuation

No. of securities held after change 623,244 Ordinary Fully Paid Shares (1) 350,000 Unlisted options for ordinary shares @ 27 cents expiring 31 December 2012 (2) Nature of change Options expired Example: on-­‐market trade, off-­‐market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-­‐back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 318] intentionally omitted <==

----- Start of picture text ----- Detail of contractNature of interestName of registered holder(if issued securities)Date of changeNo. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changedInterest acquiredInterest disposedValue/ConsiderationNote: If consideration is non-­‐cash, provide detailsand an estimated valuationInterest after change----- End of picture text -----

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	No approval required to allowoptions to lapse
If so, was prior written clearance provided to allow the tradeto proceed during this period?	No approval required for thechange in interest
If prior written clearance was provided, on what date was thisprovided?	N/A

See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3